CRP and metabolic syndrome: In this study, we aimed at determining the potential associations and clinical consequences that MetS, each of the individual criterion of MetS, circulating testosterone levels and inflammatory status (using circulating CRP levels) may have on the risk and aggressiveness of PCa.